Home
PAVM

PAVM

PAVmed Inc.

as of 12-08-2025 11:15am EST

$0.33

+$0.01

+1.55%

Stocks Health Care Medical/Dental Instruments Nasdaq

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Chart Type:

Time Range:

Founded:	2014	Country:	United States
Employees:	N/A	City:	NEW YORK
Market Cap:	9.3M	IPO Year:	2016
Target Price:	$20.00	AVG Volume (30 days):	484.1K
Analyst Decision:	Strong Buy	Number of Analysts:	1
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.22	EPS Growth:	N/A
52 Week Low/High:	$0.30 - $1.06	Next Earning Date:	11-13-2025
Revenue:	$29,000	Revenue Growth:	-99.28%
Revenue Growth (this year):	-96.97%	Revenue Growth (next year):	450.56%

AI-Powered PAVM Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold

Model Accuracy: 73.83%

73.83%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full PAVM Forecast & Prediction with Hourly Data

Compare PAVM vs Leading Stocks

See how PAVM stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free PAVM Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "PAVM PAVmed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.